Industry Overview - The vaccine industry is experiencing a structural opportunity due to the rising trend of influenza, with a focus on flu vaccine developments [2][4] - Recent approvals for clinical trials include various vaccines from companies like Zhifei Biological, including a pertussis-diphtheria-tetanus vaccine and an mRNA shingles vaccine [2][4] - The National Influenza Center reported an increase in flu activity, with a total of 621 reported influenza-like illness outbreaks across the country [4] Market Performance - The vaccine sector saw a 3% increase, with the overall pharmaceutical and biological sector rising by 3.29% during the week of November 9-15, 2025 [5] - Notable companies in the vaccine sector that performed well include Jindike, Hualan Biological, and Baike Biological, while companies like Wantai Biological and Zhifei Biological lagged [6] Valuation Metrics - The vaccine sector's price-to-earnings (PE) ratio (ttm) was 101.87X, reflecting a 2.8X increase week-over-week, while the price-to-book (PB) ratio was 1.99X, up by 0.05X [7][8] Investment Insights - The vaccine industry is under pressure, with a notable structural differentiation among companies. The focus is on innovation and international expansion as key strategies for long-term growth [9] - The industry is transitioning from scale expansion to innovation-driven growth, with supply-demand imbalances and homogenized competition causing short-term challenges [9] - Key drivers for the industry's long-term growth include policy support, demand increase due to an aging population, and technological advancements [10] Recommendations - Companies with strong research and development capabilities and differentiated product offerings, such as CanSino and Kanghua Biological, are recommended for investment [10] - Short-term focus should be on companies involved in flu vaccines due to the seasonal increase in demand [10]

Group 1 - The core viewpoint of the report highlights the performance of active quantitative funds, with a median return of 0.17% for the week of November 10-14, 2025, compared to -1.08% for the CSI 300 Index and -0.47% for the Wind All A Index. Year-to-date, the median return for active quantitative funds stands at 27.63%, outperforming the CSI 300 Index at 17.62% and the Wind All A Index at 26.58% [3][8][6] - The report indicates that the top-performing active quantitative funds for the year have returns ranging from 61% to 120%, with a concentration in the electronics and machinery sectors. Conversely, the bottom-performing funds have returns between 1% and 3%, primarily concentrated in the food and beverage sector [11][12][6] - The "Exceeding Expectations Stock Selection Strategy" is constructed based on two indicators: net profit exceeding expectations and analyst expectations. The strategy combines the top 50 stocks based on analyst expectations and the top 50-100 stocks based on year-on-year net profit exceeding expectations to form a final stock pool [5][15][16] Group 2 - The report details that the selected stocks for November 2025 include 30 stocks, with a significant concentration in the machinery sector. The highest return for the month was achieved by Joyoung Co., Ltd. (002242.SZ), with a return of 26.51% in the household appliances sector [21][26] - The performance of the selected strategy for the week of November 10-14, 2025, was 0.75%, exceeding the benchmark index (Wind All A Index) by 1.22%. For the month, the strategy's return was 0.89%, outperforming the benchmark by 0.74%. Year-to-date, the strategy has achieved a return of 47.42%, surpassing the benchmark by 20.84% [17][18][20]

Macro Strategy - Fixed asset investment in China showed a cumulative year-on-year decline of -1.70% for the first ten months of 2025, worsening from -0.50% in September. Key components such as infrastructure investment and manufacturing also experienced declines, with infrastructure down by 1.83 percentage points and manufacturing down by 1.30 percentage points. Real estate development investment saw a significant drop of -14.70% compared to -13.90% in September [2][4][5] Stock Market Overview - A-share indices experienced narrow fluctuations and slight declines from November 10 to November 14, 2025, with the Shanghai Composite Index down by 0.18% and the ChiNext Index down by 3.01%. The market is currently in a "slow bull" phase, with expectations of continued wide fluctuations and gradual upward movement in November [3][4][7] Industry Performance - Among the 31 first-level industries, most showed gains, with the top performers being comprehensive and textile sectors, which rose by 6.99% and 4.41% respectively. In contrast, the communication and electronics sectors faced declines of -4.77% each. Year-to-date, energy metals and components have seen significant increases of 92.91% and 85.55% respectively [5][6] Banking Sector Insights - The central bank's report emphasized maintaining reasonable growth in financial totals and solidifying credit support. The report indicated that recent weak credit growth is influenced by various factors, including local government debt replacement and the structural evolution of the economy. The central bank aims to keep financial totals, including credit and bond financing, growing steadily [14][15] - The central bank plans to enhance support for technology finance, which is a key focus of the 14th Five-Year Plan. This includes optimizing monetary policy tools to support technological innovation and ensuring that banks maintain reasonable net interest margins to facilitate continued support for the real economy [15][17] Investment Recommendations - The banking sector is expected to attract investment due to high dividend yields, with recommendations to focus on state-owned banks and potential valuation recovery opportunities in joint-stock and regional banks. Specific banks highlighted include Industrial and Commercial Bank of China, Bank of China, and others [17]

Investment Rating - The industry investment rating is maintained as "Buy" [2][7]. Core Views - Recent data indicates that the year-on-year decline in second-hand housing transactions in first-tier cities has narrowed, while new housing transactions remain under pressure [1][6]. - The market is entering a traditional off-season for transactions, with significant year-on-year declines in new housing sales, while second-hand housing sales are also slowing down [7]. Summary by Sections Recent Performance - In Beijing, the average daily transaction of second-hand homes was 504 units, down 14.5% year-on-year, while new homes saw a 43.3% decline with 85 units sold [4]. - In Shanghai, second-hand homes had an average daily transaction of 756 units, down 15% year-on-year, and new homes saw a 2% decline with 315 units sold [4]. - In Shenzhen, second-hand homes had an average daily transaction of 171 units, down 29%, and new homes saw a significant 77% decline with 64 units sold [5]. - For November (up to the 15th), second-hand home transactions in first-tier cities showed a year-on-year decline of 24%, while new homes declined by 47% [4][5]. Market Trends - The new housing transaction area in 30 major cities decreased by 26% year-on-year, with a notable narrowing of the decline compared to the previous week [6]. - The cumulative transaction area from January to November showed a year-on-year decline of 9.6% [6]. - The year-on-year decline in second-hand housing transactions across 13 cities was 21% for the week and 31% for November, with a cumulative increase of 5% from January to November [6]. Investment Recommendations - The report suggests focusing on leading real estate companies with strong land acquisition capabilities and land reserves in core cities, such as Poly Developments [7]. - It also highlights the potential for valuation recovery among leading intermediary firms benefiting from an increase in second-hand housing transactions, such as Wo Ai Wo Jia [7].

Investment Rating - The industry rating is maintained at "Overweight" [6][43] Core Insights - The rare earth magnetic materials industry experienced a decline of 4.08% this week, underperforming the benchmark (CSI 300) by 3 percentage points [2][10] - The current industry valuation (TTM P/E) has decreased to 73.9x, which is at the 87.2% historical percentile [10] - Short-term price fluctuations are driven by market sentiment, with no significant increase in supply expected before year-end, while demand remains positive [7][42] - The export demand is anticipated to improve following the easing of export controls, which may lead to a recovery in prices and industry sentiment [43][44] Market Performance - The industry has shown relative performance of -18% over the past month, -1% over three months, and +47% over the past year [6] - Absolute performance indicates a decline of -16% over the past month, an increase of +10% over three months, and +61% over the past year [6] Price Trends - Rare earth concentrate prices have shown a slight decline, with mixed carbonate rare earth ore prices dropping by 2.78% [3][12] - Praseodymium-neodymium prices have fluctuated, with an average decrease of 1.8% for praseodymium oxide and 1.03% for praseodymium metal [14][15] - Dysprosium prices have continued to decline, with a decrease of 2.58% for dysprosium oxide [19] - Neodymium-iron-boron sintered block prices have also decreased, with N35 and H35 grades falling by 1.45% and 0.96%, respectively [38] Supply and Demand Dynamics - The supply side is characterized by a tight balance, with expectations of reduced output in November due to lower operating rates [42] - Demand remains stable, with improved foreign orders and good domestic demand, particularly in the magnetic materials sector [42][43] - The overall trend in the industrial sector is positive, although growth in downstream sectors like new energy vehicles and air conditioning is expected to slow [42] Valuation and Performance Outlook - Current absolute and relative valuation levels are supported by loose liquidity and favorable industrial policies, but high valuations may face pressure due to declining market risk appetite [42][43] - The industry is expected to enter a phase of stabilization after recent adjustments, with potential for price recovery and improved sentiment in the near term [43][44]

Investment Rating - The industry rating is maintained at "Overweight" [10] Core Views - The report emphasizes maintaining reasonable growth in financial totals and stabilizing credit support [7][32] - The central bank's monetary policy aims for moderate easing, ensuring relatively loose social financing conditions while enhancing policy execution and transmission [8][32] - The report highlights the importance of maintaining a reasonable net interest margin to expand monetary policy space [9][33] Summary by Sections Industry Performance - The banking index increased by 1.70% during the period from November 10 to November 16, 2025, outperforming the CSI 300 index by 2.78 percentage points [12] - Large banks showed a leading market performance with a growth of 3.19% [12] Monetary Policy Insights - The central bank's report indicates that the overall economic operation is stable, although recent investment has weakened, affecting social financing growth [8][32] - The central bank believes that a slight decrease in loan growth reflects changes in the financial supply side, which is considered reasonable [8][32] Credit and Financing - Recent credit growth has been weak, primarily due to local special bond replacements and the evolution of the economic structure [8][32] - The report suggests that the effectiveness of policy financial tools in supporting project financing is yet to be seen [10][35] Investment Recommendations - The report recommends focusing on state-owned banks for stable high dividend investment value and potential valuation recovery opportunities for joint-stock and regional banks [10][35] - Specific banks recommended include Industrial and Commercial Bank of China, Bank of China, CITIC Bank, Jiangsu Bank, Shanghai Rural Commercial Bank, Chongqing Rural Commercial Bank, and Suzhou Bank [10][35]

Investment Rating - The industry investment rating is maintained at "Overweight" [2][22] Core Insights - The retail sector saw a 4.06% increase last week, outperforming the CSI 300 index by 5.14 percentage points [2][7] - The total sales during the 2025 "Double Eleven" shopping festival reached 16,950 billion, a year-on-year increase of 14.2% [4][20] - The current PE ratio for the retail sector is 51.03X, with a PB ratio of 2.06X [3][15][18] Industry Performance - The retail sector's performance over the past month shows a relative return of 4.6%, a 3-month return of -2.7%, and a 12-month return of 2.3% [2] - The retail sector's absolute returns were 4.4% over the past month, 8.1% over the past 3 months, and 18.9% over the past year [2] Industry Dynamics - The "Double Eleven" shopping festival highlighted a shift in consumer behavior towards rational spending, with a focus on quality and brand value [4][20] - The home appliance sector is expected to maintain strong growth due to ongoing subsidy policies, while competition is evolving towards AI empowerment and green solutions [4][20] - The beauty industry is experiencing significant structural upgrades, with a focus on high-end products and effective performance [4][20] Investment Recommendations - The report suggests focusing on sectors that emphasize experience, content, and community engagement, particularly in smart home appliances and beauty care [4][21][22] - Attention is recommended for high-end domestic beauty brands and the instant retail supply chain during the "Double Eleven" period [5][22]

Investment Rating - The industry rating is maintained at "Overweight" [6] Core Views - The Chinese medicine industry is experiencing steady progress in centralized procurement, with a focus on companies that have advantages in product variety, quality, and cost [5][9] - The market performance of the Chinese medicine sector has shown a 4.08% increase recently, ranking third among secondary sub-sectors [2][13] - The price governance policies are expected to lead to a clearer differentiation within the industry, benefiting companies with competitive advantages [10][11] Market Performance - The Chinese medicine sector's PE (ttm) is 29.25X, which has increased by 1.14X week-on-week, while the PB (lf) is 2.47X, up by 0.1X [3] - The overall market for Chinese medicinal materials is experiencing volatility, with a recent price index of 225.47 points, down 0.2% from the previous week [4] Centralized Procurement - The fourth batch of centralized procurement for traditional Chinese medicine has been initiated, with significant competition in certain product groups [5] - The "3+N" alliance in the Beijing-Tianjin-Hebei region has also started procurement for 200 types of Chinese medicine formula granules [5] Investment Suggestions - Focus on three main lines: price governance, consumption recovery, and state-owned enterprise reform [10][11] - Recommended companies include Zhaoli Pharmaceutical and Yiling Pharmaceutical, with a watch on Pizaihuang and Shouxiangu [11]

行业评级：买入（维持） 证券研究报告 2025 年 11 月 16 日 湘财证券研究所 行业研究 机械行业周报 近十二个月行业表现 % 1 个月 3 个月 12 个月 相对收益 -3.3 -5.2 16.5 绝对收益 -2.8 5.0 33.1 -20% -10% 0% 10% 20% 30% 40% 50% 24/11 25/01 25/03 25/05 25/07 25/09 机械设备(申万) 沪深300 关注锂电专用设备、机床工具、机器人 相关研究： 注：相对收益与沪深 300 相比 分析师：轩鹏程 证书编号：S0500521070003 Tel：(8621) 50295321 Email：xuanpc@xcsc.com 地址：上海市浦东新区银城路88号 中国人寿金融中心10楼 ——机械行业周报（2025.11.10~2025.11.14） 核心要点： ❑ 锂电专用设备：10 月我国新能源汽车销量同比增长 19.9% 根据 Wind 数据，2025 年 10 月，我国新能源汽车销量约 171.5 万 辆，同比增长 19.9%，1-10 月我国新能源汽车总销量约 1294.3 万辆， 同比增长 32.7% ...

Investment Rating - The report maintains a "Buy" rating for the food and beverage industry [2] Core Insights - The food and beverage industry experienced a slight decline of 0.56% from November 3 to November 7, while the overall market indices showed mixed results, with the Shanghai Composite Index down by 0.18% and the Shenzhen Component Index down by 1.40% [5][10] - The industry valuation is currently at a low level, with a Price-to-Earnings (PE) ratio of 22X as of November 14, 2025, ranking 23rd among Shenwan's primary industries [5][15] - The Consumer Price Index (CPI) showed a year-on-year increase of 0.2% in October, indicating a recovery in consumer sentiment, particularly in service consumption [6][8] Summary by Sections Industry Performance - The food and beverage sector outperformed the broader market, with a 2.82% increase, ranking 6th out of 31 sectors [5][10] - Sub-sectors such as pre-processed foods, baked goods, and dairy products saw increases of 6.93%, 5.07%, and 4.33% respectively [5][10] Valuation Metrics - The food and beverage industry's PE ratio is 22X, with other alcoholic beverages at 58X, health products at 38X, and snacks at 36X, while white spirits, beer, and pre-processed foods have lower valuations at 20X, 23X, and 23X respectively [15] Consumer Trends - The CPI's increase is attributed to policies aimed at boosting domestic demand and the impact of the National Day and Mid-Autumn Festival holidays [6] - Food prices saw a decline of 2.9% year-on-year, with dairy prices down by 1.7% and alcoholic beverages down by 2.0% [7] Investment Recommendations - The report suggests focusing on companies with stable demand and strong risk resilience, as well as those innovating in new products, channels, and consumption scenarios [8][42] - Recommended companies include New Dairy, Andeli, Shanxi Fenjiu, Guizhou Moutai, and Yanjinpuzi [8][42]